Nasdaq

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

WAYNE, Pa., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the enrollment of the first patient in the DUBSTENT ...
Nasdaq

Teleflex Incorporated Announces Definitive Agreement to Acquire Vascular Intervention Business from BIOTRONIK for €760 Million

Teleflex Incorporated has announced its agreement to acquire most of the Vascular Intervention business from BIOTRONIK SE & Co. KG for approximately €760 million, pending regulatory approvals and ...
Healio

FDA grants breakthrough device designation for resorbable magnesium scaffold for CLTI

Please provide your email address to receive an email when new articles are posted on . A below-the-knee resorbable magnesium scaffold to treat CLTI received FDA breakthrough device designation. When ...
Finanznachrichten

Teleflex Incorporated: Teleflex to Acquire BIOTRONIK's Vascular Intervention Business

WAYNE, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire ...